litlas
Log inCreate account

Manuela Ferracin

Active 2004–2025

101
Papers
34,820
Citations
63
h-index
95
i10-index

Citations

Citations per year for Manuela Ferracin1975: 1 citations1986: 1 citations1992: 5 citations1996: 2 citations1999: 1 citations2001: 1 citations2002: 1 citations2003: 1 citations2004: 8 citations2005: 72 citations2006: 300 citations2007: 562 citations2008: 934 citations2009: 1,022 citations2010: 1,020 citations2011: 925 citations2012: 837 citations2013: 713 citations2014: 545 citations2015: 450 citations2016: 360 citations2017: 411 citations2018: 279 citations2019: 954 citations2020: 971 citations2021: 874 citations2022: 597 citations2023: 443 citations2024: 698 citations2025: 342 citations2026: 15 citations1976–1985: no citations, so these years are not shown1987–1991: no citations, so these years are not shown1993–1995: no citations, so these years are not shown1997–1998: no citations, so these years are not shown2000: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,293 citing papers, 24.2% of this breakdownChina: 2,721 citing papers, 20% of this breakdownItaly: 921 citing papers, 6.8% of this breakdownGermany: 545 citing papers, 4% of this breakdownUnited Kingdom: 521 citing papers, 3.8% of this breakdownJapan: 379 citing papers, 2.8% of this breakdownIndia: 331 citing papers, 2.4% of this breakdownIran: 311 citing papers, 2.3% of this breakdownSpain: 294 citing papers, 2.1% of this breakdownCanada: 293 citing papers, 2.1% of this breakdownAustralia: 289 citing papers, 2.1% of this breakdownFrance: 289 citing papers, 2.1% of this breakdown
0%24.2%Other 25.3%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology78.2%
  • Medicine17.6%
  • Immunology and Microbiology1.8%
  • Neuroscience0.7%
  • Engineering0.4%
  • Agricultural and Biological Sciences0.3%
  • Other1%

Topics

  • MicroRNA in disease regulation20.9%
  • Cancer-related molecular mechanisms research12.7%
  • Circular RNAs in diseases11.7%
  • RNA modifications and cancer5%
  • RNA Interference and Gene Delivery2.9%
  • Extracellular vesicles in disease2.8%
  • Other44%

Coauthors

All papers

Open in search
  1. Non-coding RNAs in disease: from mechanisms to therapeutics

    Authors: Kinga Németh, Recep Bayraktar, Manuela Ferracin, George A. Călin - Nature Reviews Genetics 2023 cited by 807

  2. A microRNA expression signature of human solid tumors defines cancer gene targets

    Authors: Stefano Volinia, George A. Calin, Chang‐Gong Liu, Stefan Ambs, Amelia Cimmino, Fabio Petrocca, Rosa Visone, Marilena V. Iorio, Claudia Roldo, Manuela Ferracin, Robyn L. Prueitt, Nozumu Yanaihara, Giovanni Lanza, Aldo Scarpa, Andrea Vecchione, Massimo Negrini, Curtis C. Harris, Carlo M. Croce - National Academy of Sciences, Proceedings of the National Academy of Sciences 2006 cited by 5,696

  3. miR-15 and miR-16 induce apoptosis by targeting BCL2

    Authors: Amelia Cimmino, George A. Calin, Muller Fabbri, Marilena V. Iorio, Manuela Ferracin, Masayoshi Shimizu, Sylwia E. Wojcik, Rami I. Aqeilan, Simona Zupo, Mariella Dono, Laura Z. Rassenti, Hansjüerg Alder, Stefano Volinia, Chang‐Gong Liu, Thomas J. Kipps, Massimo Negrini, Carlo M. Croce - National Academy of Sciences, Proceedings of the National Academy of Sciences 2005 cited by 3,521

  4. MicroRNA Gene Expression Deregulation in Human Breast Cancer

    Authors: Marilena V. Iorio, Manuela Ferracin, Chang‐Gong Liu, Angelo Veronese, Riccardo Spizzo, Silvia Sabbioni, Eros Magri, Massimo Pedriali, Muller Fabbri, Manuela Campiglio, Sylvie Ménard, Juan Palazzo, Anne Rosenberg, Piero Musiani, Stefano Volinia, Italo Nenci, George A. Calin, Patrizia Querzoli, Massimo Negrini, Carlo M. Croce - Cancer Research 2005 cited by 4,059

  5. Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B

    Authors: Paola Fisicaro, Valeria Barili, Barbara Montanini, Greta Acerbi, Manuela Ferracin, Francesca Guerrieri, Debora Salerno, Carolina Boni, Marco Massari, Maria Cristina Cavallo, G. Grossi, T. Giuberti, Pietro Lampertico, Gabriele Missale, Massimo Levrero, Simone Ottonello, Carlo Ferrari - Nature Medicine 2017 cited by 343

  6. Basal Cell Carcinoma: A Comprehensive Review

    Authors: Emi Dika, Federica Scarfì, Manuela Ferracin, Elisabetta Broseghini, Emanuela Marcelli, Barbara Bortolani, Elena Campione, Mattia Riefolo, Costantino Ricci, Martina Lambertini - International Journal of Molecular Sciences 2020 cited by 195

  7. Small extracellular vesicles deliver miR‐21 and miR‐217 as pro‐senescence effectors to endothelial cells

    Authors: Emanuela Mensa’, Michele Guescini, Angelica Giuliani, Maria Giulia Bacalini, Deborah Ramini, Giacomo Corleone, Manuela Ferracin, Gianluca Fulgenzi, Laura Graciotti, Francesco Prattichizzo, Leonardo Sorci, Michela Battistelli, Vladia Monsurrò, Anna Rita Bonfigli, Maurizio Cardelli, Rina Recchioni, Fiorella Marcheselli, Silvia Latini, Serena Maggio, Mirco Fanelli, Stefano Amatori, Gianluca Storci, Antonio Ceriello, Vilberto Stocchi, María De Luca, Luca Magnani, Maria Rita Rippo, Antonio Domenico Procopio, Claudia Sala, Iva Budimir, Cristian Bassi, Massimo Negrini, Paolo Garagnani, Claudio Franceschi, Jacopo Sabbatinelli, Massimiliano Bonafè, Fabiola Olivieri - Journal of Extracellular Vesicles 2020 cited by 187

  8. P2X7 promotes metastatic spreading and triggers release of miRNA-containing exosomes and microvesicles from melanoma cells

    Authors: Anna Pegoraro, Elena De Marchi, Manuela Ferracin, Elisa Orioli, Michele Zanoni, Cristian Bassi, Anna Tesei, Marina Capece, Emi Dika, Massimo Negrini, Francesco Di Virgilio, Elena Adinolfi - Cell Death and Disease 2021 cited by 99

  9. The Long Noncoding RNA CCAT2 Induces Chromosomal Instability Through BOP1-AURKB Signaling

    Authors: Baoqing Chen, Mihnea P. Dragomir, Linda Fabris, Recep Bayraktar, Erik Knutsen, Xu Liu, Changyan Tang, Yongfeng Li, Tadanobu Shimura, Tina Catela Ivković, Mireia Cruz De los Santos, Simone Anfossi, Masayoshi Shimizu, Maitri Shah, Hui Ling, Peng Shen, Asha S. Multani, Barbara Pardini, Jared K. Burks, Hiroyuki Katayama, Lucas C. Reineke, Longfei Huo, Muddassir Syed, Shumei Song, Manuela Ferracin, Eiji Oki, Bastian Fromm, Cristina Ivan, Krithika Bhuvaneshwar, Yuriy Gusev, Koshi Mimori, David G. Menter, Subrata Sen, Takatoshi Matsuyama, Hiroyuki Uetake, Cătălin Vasilescu, Scott Kopetz, Jan Parker‐Thornburg, Ayumu Taguchi, Samir Hanash, Leonard Girnita, Ondřej Slabý, Ajay Goel, Gabriele Varani, Mihai Gagea, Chunlai Li, Jaffer A. Ajani, George A. Călin - Gastroenterology 2020 cited by 131

  10. A MicroRNA Signature of Hypoxia

    Authors: Ritu Kulshreshtha, Manuela Ferracin, Sylwia E. Wojcik, Ramiro Garzon, Hansjüerg Alder, Francisco Agosto-Perez, Ramana V. Davuluri, Chang‐Gong Liu, Carlo M. Croce, Massimo Negrini, George A. Calin, Mircea Ivan - Molecular and Cellular Biology 2006 cited by 1,062

  11. MiR-494 induces metabolic changes through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma

    Authors: Christian Bergamini, Ilaria Leoni, Nicola Rizzardi, Mattia Melli, Giuseppe Galvani, Camelia Alexandra Coadǎ, Catia Giovannini, Elisa Monti, Irene Liparulo, Francesca Valenti, Manuela Ferracin, Matteo Ravaioli, Matteo Cescon, Francesco Vasuri, Fabio Piscaglia, Massimo Negrini, Claudio Stefanelli, Romana Fato, Laura Gramantieri, Francesca Fornari - Journal of Experimental & Clinical Cancer Research 2023 cited by 37

  12. MiR-15a and miR-16-1 cluster functions in human leukemia

    Authors: George A. Calin, Amelia Cimmino, Muller Fabbri, Manuela Ferracin, Sylwia E. Wojcik, Masayoshi Shimizu, Cristian Taccioli, Nicola Zanesi, Ramiro Garzon, Rami I. Aqeilan, Hansjüerg Alder, Stefano Volinia, Laura Z. Rassenti, Xiuping Liu, Chang‐Gong Liu, Thomas J. Kipps, Massimo Negrini, Carlo M. Croce - National Academy of Sciences, Proceedings of the National Academy of Sciences 2008 cited by 806

  13. CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer

    Authors: Hui Ling, Riccardo Spizzo, Yaser Atlasi, Milena S. Nicoloso, Masayoshi Shimizu, Roxana S. Redis, Naohiro Nishida, Roberta Gafà, Jian H. Song, Zhiyi Guo, Cristina Ivan, Elisa Barbarotto, Ingrid de Vries, Xinna Zhang, Manuela Ferracin, Mike Churchman, Janneke F. van Galen, Berna Beverloo, Maryam Shariati, Franziska Haderk, Marcos R. Estecio, Guillermo Garcia‐Manero, Gijs A. Patijn, D. C. Gotley, Vikas Bhardwaj, Imad Shureiqi, Subrata Sen, Asha S. Multani, James Welsh, Ken Yamamoto, Itsuki Taniguchi, Min‐Ae Song, Steven Gallinger, Graham Casey, Stephen N. Thibodeau, Loı̈c Le Marchand, Maarit Tiirikainen, Sendurai A. Mani, Wei Zhang, Ramana V. Davuluri, Koshi Mimori, Masaki Mori, Anieta M. Sieuwerts, John W.M. Martens, Ian Tomlinson, Massimo Negrini, Ioana Berindan‐Neagoe, John A. Foekens, Stanley R. Hamilton, Giovanni Lanza, Scott Kopetz, Riccardo Fodde, George A. Călin - Genome Research 2013 cited by 611

  14. A MicroRNA Signature Associated with Prognosis and Progression in Chronic Lymphocytic Leukemia

    Authors: George A. Calin, Manuela Ferracin, Amelia Cimmino, Gianpiero Di Leva, Masayoshi Shimizu, Sylwia E. Wojcik, Marilena V. Iorio, Rosa Visone, Nurettin İlter Sever, Muller Fabbri, Rodolfo Iuliano, Tiziana Palumbo, Flavia Pichiorri, Claudia Roldo, Ramiro Garzon, Cinzia Sevignani, Laura Z. Rassenti, Hansjüerg Alder, Stefano Volinia, Chang‐Gong Liu, Thomas J. Kipps, Massimo Negrini, Carlo M. Croce - New England Journal of Medicine 2005 cited by 2,412

  15. Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers

    Authors: Katrien Van Roosbroeck, Francesca Fanini, Tetsuro Setoyama, Cristina Ivan, Cristian Rodriguez‐Aguayo, Enrique Fuentes‐Mattei, Lianchun Xiao, Ivan Vannini, Roxana S. Redis, Lucilla D’Abundo, Xinna Zhang, Milena S. Nicoloso, Simona Rossi, Vianey González-Villasana, Rajesha Rupaimoole, Manuela Ferracin, Fortunato Morabito, Antonino Neri, Peter P. Ruvolo, Vivian Ruvolo, Chad V. Pecot, Dino Amadori, Lynne V. Abruzzo, Steliana Calin, Xuemei Wang, M. James You, Alessandra Ferrajoli, Robert Z. Orlowski, William Plunkett, Tara M. Lichtenberg, Ramana V. Davuluri, Ioana Berindan‐Neagoe, Massimo Negrini, Ignacio I. Wistuba, Hagop M. Kantarjian, Anil K. Sood, Gabriel Lopez‐Berestein, Michael J. Keating, Muller Fabbri, George A. Călin - Clinical Cancer Research 2016 cited by 184

  16. Cyclin G1 Is a Target of miR-122a, a MicroRNA Frequently Down-regulated in Human Hepatocellular Carcinoma

    Authors: Laura Gramantieri, Manuela Ferracin, Francesca Fornari, Angelo Veronese, Silvia Sabbioni, Chang‐Gong Liu, George A. Calin, Catia Giovannini, Eros Ferrazzí, Gian Luca Grazi, Carlo M. Croce, Luigi Bolondi, Massimo Negrini - Cancer Research 2007 cited by 812

  17. MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma

    Authors: Francesca Fornari, Laura Gramantieri, Manuela Ferracin, Angelo Veronese, Silvia Sabbioni, George A. Calin, Gian Luca Grazi, Catia Giovannini, C M Croce, Luigi Bolondi, Massimo Negrini - Oncogene 2008 cited by 641

  18. The P2X7 receptor is a key modulator of the PI3K/GSK3β/VEGF signaling network: evidence in experimental neuroblastoma

    Authors: Francesca Amoroso, Marina Capece, Antonio Rotondò, Davide Cangelosi, Manuela Ferracin, Alessia Franceschini, Lizzia Raffaghello, Vito Pistoia, Luigi Varesio, Elena Adinolfi - Oncogene 2015 cited by 202

  19. Extensive modulation of a set of microRNAs in primary glioblastoma

    Authors: Silvia Anna Ciafrè, Silvia Galardi, Annunziato Mangiola, Manuela Ferracin, C.-G. Liu, Giovanni Sabatino, Massimo Negrini, G. Maira, Carlo M. Croce, M.G. Farace - Biochemical and Biophysical Research Communications 2005 cited by 1,098

  20. Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations

    Authors: Patrizia Nanni, Lorena Landuzzi, Maria Cristina Manara, Alberto Righi, Giordano Nicoletti, Camilla Cristalli, Michela Pasello, Alessandro Parra, Marianna Carrabotta, Manuela Ferracin, Arianna Palladini, Marianna L. Ianzano, Veronica Giusti, Francesca Ruzzi, Mauro Magnani, Davide María Donati, Piero Picci, Pier‐Luigi Lollini, Katia Scotlandi - Scientific Reports 2019 cited by 75

  21. One-Step and Real-Time Detection of microRNA-21 in Human Samples for Lung Cancer Biosensing Diagnosis

    Authors: Olalla Calvo-Lozano, Pablo García-Aparicio, Lajos Ráduly, M.‐Carmen Estévez, Ioana Berindan‐Neagoe, Manuela Ferracin, Laura M. Lechuga - Analytical Chemistry 2022 cited by 52

  22. ARID1A in cancer: Friend or foe?

    Authors: Beatrice Fontana, Giulia Gallerani, Irene Salamon, Ilaria Pace, Roberta Roncarati, Manuela Ferracin - Frontiers in Oncology 2023 cited by 48

  23. Modulation of mismatch repair and genomic stability by miR-155

    Authors: Nicola Valeri, Pierluigi Gasparini, Muller Fabbri, Chiara Braconi, Angelo Veronese, Francesca Lovat, Brett Adair, Ivan Vannini, Francesca Fanini, Arianna Bottoni, Stefan Costinean, Sukhinder K. Sandhu, Gerard J. Nuovo, Hansjüerg Alder, Roberta Gafà, Federica Calore, Manuela Ferracin, Giovanni Lanza, Stefano Volinia, Massimo Negrini, Michael A. McIlhatton, Dino Amadori, Richard Fishel, Carlo M. Croce - National Academy of Sciences, Proceedings of the National Academy of Sciences 2010 cited by 350

  24. Resveratrol decreases the levels of miR-155 by upregulating miR-663, a microRNA targeting JunB and JunD

    Authors: Esmerina Tili, Jean‐Jacques Michaille, Brett Adair, Hansjüerg Alder, Emeric Limagne, Cristian Taccioli, Manuela Ferracin, Dominique Delmas, Norbert Latruffe, Carlo M. Croce - Carcinogenesis 2010 cited by 271